Active Ingredient(s): Sulfinpyrazone
FDA Approved: * May 13, 1959
Pharm Company: * NOVARTIS
Category: Gout

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Anturane Overview

Sulfinpyrazone is a uricosuric medication used to treat gout. It also sometimes is used to reduce platelet aggregation by inhibiting degranulation of platelets which reduces the release of ADP and thromboxane. Like other uricosurics, sulfinpyrazone works by competitively inhibiting uric acid reabsorption in the proximal tubule of the kidney. Contraindications Sulfinpyrazone must not be used in persons with renal impairment or a history of uric acid kidney stones.[1] Re...

Read more Anturane Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Anturane Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Capsule: 200mg
  • Tablet: 100mg, 100mg *federal register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Sulfinpyrazone or a similar ingredient: (1 result)